Chemistry World

Crispr gene-editing technology offers new hope for HIV cure but faces delivery challenges

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
PM News on MSN

Breakthrough in Science as US sends HIV prevention drugs to Africa

Lenacapavir is an injectable medicine that only needs to be taken twice a year, making it easier to use than daily HIV pills.
Devdiscourse

SA Adds Breakthrough HIV Injection Lenacapavir to Essential Medicines List

The Department of Health said the decision reflects its mandate to ensure that all citizens have access to safe, effective, ...
The South African on MSN

The HIV-prevention jab is here: What you need to know…

You can now be vaccinated against HIV – but that does not mean you can be reckless, warns the Department of Health ...

Gilead Joins Partners for Delivery of First Shipments of Breakthrough Twice-yearly Lenacapavir for HIV Prevention to Sub-Saharan Africa

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the delivery of first shipments of lenacapavir – Gilead’s twice-yearly ...

World’s deadliest disease might soon have a cure: Breakthrough tuberculosis vaccine marks first major progress in 100 years

Scientists at MIT have identified 24 protein fragments that could form a new tuberculosis vaccine, offering a potential ...
Medscape

Important Long-COVID Lessons From AIDS Researchers

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

Injectable PrEP approved in Northern Ireland following NHS milestone in monumental HIV breakthrough

"Eligible patients in Northern Ireland may receive this treatment," says the Department of Health The post Injectable PrEP ...

Warning signs of HIV AIDS and 5 doctor-backed tips that can change everything

Women are disproportionately affected by HIV, making up nearly half of new infections globally and in India. Stigma, gender ...

HIV knows no borders, and the Trump administration's new strategy leaves Americans vulnerable, expert explains

Protecting public health abroad benefits Americans. In a globalized world, diseases and their social and economic impacts do ...

Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV-1 Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-1 Trial

Gilead Sciences, Inc. (NASDAQ: GILD) today announced positive topline results from the Phase 3 ARTISTRY-1 trial. The ...
Opinion

HIV knows no borders, and the Trump administration’s new strategy leave Americans vulnerable – an HIV-prevention expert explains

The Trump administration’s new global HIV prevention strategy prioritizes preventing mother-to-child HIV transmission. About 120,000 children under the age of 5 were newly infected with HIV in 2024, ...